Trailing-twelve-month (TTM) revenue is $11.86 Million with a year-over-year growth of (40.26%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $5,429,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-20 |
| Q4 FY2025Period ended 2025-12-31 | $1,867,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q1 FY2026Period ended 2026-03-31 | $1,475,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q2 FY2026Period ended 2026-06-30 | $3,092,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $11,863,000 |
Current P/S: $169,961,457 market capitalization ÷ $11,863,000 TTM revenue = 14.33x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:23:52.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $3.09M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:32:56.424Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2020-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD |
|---|---|
| USA | $18M |
$11.86M
$11.86 Million
(40.26%)
vs. $19.86M a year ago (TTM)
(13.99%)
5 Year compound annual growth rate
1 Year
(40.26%)
3 Year
(23.00%)
5 Year
(13.99%)
10 Year
+28.34%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $16.96M | ($3.26M) | (16.14%) |
| 2024 | $20.22M | +$1.54M | +8.22% |
| 2023 | $18.69M | ($7.81M) | (29.48%) |
| 2022 | $26.50M | +$2.73M | +11.50% |
| 2021 | $23.76M | +$2.00M | +9.19% |
| 2020 |
TTM Growth
(40.26%)
3-Year CAGR
(23.00%)
5-Year CAGR
(13.99%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 36 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:32:56.424Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $21.76M |
| ($10.03M) |
| (31.54%) |
| 2019 | $31.79M | +$28.39M | +834.70% |
| 2018 | $3.40M | +$905,000 | +36.26% |
| 2017 | $2.50M | +$938,000 | +60.21% |
| 2016 | $1.56M | +$957,000 | +159.23% |
